Information Library
Results for: Clinical and marketing materials - Cost control/reduction
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Population PK/PD - Modeling and Simulation Optimization Tools
Brochure — February 11, 2011
Population pharmacokinetic/ pharmacodynamic (PK/PD) modeling and simulation, available from Quintiles, is now endorsed by the FDA as often being instrumental in drug approval and labeling. -
Commercial – Identify, Promote and Prove Treatment Value
Brochure — April 1, 2010
Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success. -
Early phase strategies
Hear from the Experts — June 15, 2009
Web cast about Early Phase Strategies. -
Risk Assessment & Strategy
Brochure — April 16, 2009
Quintiles benefit risk analysis can help you anticipate potential regulatory concerns and highlight the benefit side of your drug’s benefit risk profile. -
Maneuvering a Drifting Project Back on Course
Case Study — March 25, 2009
The NDA had been drifting within the FDA for years, and now it was subject to intense scrutiny by two agency reviewers.
Page 1 of 1 (5 results)
